<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">An Pediatr (Barc)</span><span class="iso-abbrev" title="iso-abbrev">An Pediatr (Barc)</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Anales De Pediatria (Barcelona, Spain : 2003)</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1695-4033</span><span class="issn-epub" tagx="issn" title="issn-epub">1695-9531</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">AsociaciÃ³n EspaÃ±ola de PediatrÃ­a. Published by Elsevier EspaÃ±a, S.L.U.</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7457908">7457908</a></span><span class="publisher-id" title="publisher-id">S1695-4033(20)30283-6</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.anpedi.2020.07.025">10.1016/j.anpedi.2020.07.025</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Original</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Espectro clÃ­nico y factores de riesgo de enfermedad complicada en niÃ±os ingresados con infecciÃ³n por SARS-CoV-2</div><span class="trans-title-group" tagx="trans-title-group" title="trans-title-group"><span class="trans-title" tagx="trans-title" title="trans-title">Clinical spectrum and risk factors for complicated disease course in children admitted with SARS-CoV-2 infection</span></span></div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Storch-de-Gracia</span><span class="given-names" tagx="given-names" title="given-names">Pilar</span></span><a href="#aff0005">a</a><a href="#cor0005">â�Ž</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leoz-Gordillo</span><span class="given-names" tagx="given-names" title="given-names">InÃ©s</span></span><a href="#aff0010">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Andina</span><span class="given-names" tagx="given-names" title="given-names">David</span></span><a href="#aff0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Flores</span><span class="given-names" tagx="given-names" title="given-names">Patricia</span></span><a href="#aff0015">c</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Villalobos</span><span class="given-names" tagx="given-names" title="given-names">Enrique</span></span><a href="#aff0015">c</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Escalada-Pellitero</span><span class="given-names" tagx="given-names" title="given-names">Silvia</span></span><a href="#aff0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">JimÃ©nez</span><span class="given-names" tagx="given-names" title="given-names">Raquel</span></span><a href="#aff0015">c</a></span><span class="citation_author_institution" id="aff0005">[a], </span><span class="citation_author_institution" id="aff0010">[b], </span><span class="citation_author_institution" id="aff0015">[c], </span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">â�Ž</span>Autor para correspondencia.</div> </div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-8-8</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-8-8</span></span><span class="history" title="history"><span class="received" title="received">received: 2020-7-13</span><span class="accepted" title="accepted">accepted: 2020-7-29</span></span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">AsociaciÃ³n EspaÃ±ola de PediatrÃ­a</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="introducciÃ³n" title="sec"> <div class="title" tagx="title" title="title">
IntroducciÃ³n</div> <p>En este momento existen todavÃ­a grandes interrogantes acerca de las caracterÃ­sticas de enfermedad causada por el nuevo coronavirus (COVID-19) en los niÃ±os, asÃ­ como acerca de los factores asociados al desarrollo de formas graves de la enfermedad.</p> </div> <div class="mÃ©todos" title="sec"> <div class="title" tagx="title" title="title">
MÃ©todos</div> <p>Estudio retrospectivo que incluye pacientes menores de 18 aÃ±os ingresados debido a infecciÃ³n por SARS-CoV-2. La infecciÃ³n fue confirmada por la reacciÃ³n en cadena de la transcriptasa inversa-polimerasa (RT-PCR) en tiempo real o por serologÃ­a. Describimos los datos epidemiolÃ³gicos y clÃ­nicos, los hallazgos de laboratorio y de imÃ¡genes, asÃ­ como el tratamiento y la evoluciÃ³n de estos pacientes. Los pacientes se clasificaron en dos grupos de gravedad y luego se compararon.</p> </div> <div class="resultados" title="sec"> <div class="title" tagx="title" title="title"><i>Resultados</i></div> <p>Se incluyeron 39 niÃ±os, con una mediana de edad de nueve aÃ±os (rango 12 dÃ­as-16 aÃ±os); 23 eran varones. Los casos con evoluciÃ³n no complicada (24) se presentaron en su mayorÃ­a con fiebre y/o sÃ­ntomas respiratorios sin alteraciones significativas en los hallazgos de laboratorio. De los 15 niÃ±os con enfermedad complicada, 12 desarrollaron <i>shock</i>. AdemÃ¡s de la fiebre, frecuentemente presentaban alteraciones de la apariencia, taquicardia extrema, dolor abdominal, vÃ³mitos, diarrea, erupciÃ³n cutÃ¡nea y/o hiperemia conjuntival. TambiÃ©n mostraron mayor linfopenia (p = 0,001), elevaciÃ³n de la proporciÃ³n neutrÃ³filos/linfocitos (p = 0,001), proteÃ­na C reactiva (p &amp;lt; 0,001), procalcitonina (p = 0,001), dÃ­mero D (p &amp;lt; 0,001) y ferritina (p &amp;lt; 0,001).</p> </div> <div class="conclusiones" title="sec"> <div class="title" tagx="title" title="title">
Conclusiones</div> <p>La infecciÃ³n por SARS-CoV-2 en niÃ±os ingresados se presenta con una gran variabilidad clÃ­nica. Cuando se les proporciona tratamiento de soporte, los pacientes con sÃ­ntomas respiratorios que no tienen alteraciÃ³n de las pruebas de laboratorio, generalmente tienen una enfermedad no complicada. Los pacientes con enfermedad complicada se presentan principalmente con fiebre y sÃ­ntomas abdominales y/o mucocutÃ¡neos, la mayorÃ­a desarrollan un <i>shock</i>. La elevaciÃ³n de los marcadores inflamatorios puede permitir una detecciÃ³n temprana y el pronÃ³stico final es bueno.</p> </div> </div><span class="trans-abstract" tagx="trans-abstract" title="trans-abstract"> <div class="introduction" title="sec"> <div class="title" tagx="title" title="title">
Introduction</div> <p>At this time there are still major questions about the characteristics of disease caused by the new coronavirus (COVID-19) in children as well as factors associated with the development of severe forms of the disease.</p> </div> <div class="studydesign" title="sec"> <div class="title" tagx="title" title="title">
Study design</div> <p>Retrospective study including patients under 18 years of age admitted with SARS-CoV-2 infection from March 1 to April 30, 2020. Infection was confirmed by realtime reverse transcriptaseâ€"polymerase chain reaction (RT-PCR) or antibody testing. We describe the epidemiological and clinical data, laboratory and imaging findings, as well as treatment and outcome in these patients. In light of these findings, patients were classified into two severity groups and then compared.</p> </div> <div class="results" title="sec"> <div class="title" tagx="title" title="title">
Results</div> <p>Thirty-nine children were included, with a median age of 9 years (range 12 days-16 years); 23 were boys. Cases with uncomplicated disease course (24) mostly presented to the emergency department (ED) with fever and/or respiratory symptoms without significant alterations in laboratory findings. Of the 15 children with a complicated course, 12 developed shock. In addition to fever, they frequently presented altered appearance, extreme tachycardia, abdominal pain, vomiting, diarrhea, rash, and/or conjunctival hyperemia. They also showed greater lymphopenia (p = 0.001), elevated neutrophil/lymphocyte ratio (p = 0.001), C-reactive protein (p &amp;lt; 0.001), procalcitonin (p = 0.001), D-dimer (p &amp;lt; 0.001), and ferritin (p &amp;lt; 0.001).</p> </div> <div class="conclusions" title="sec"> <div class="title" tagx="title" title="title">
Conclusions</div> <p>SARS-CoV-2 infection in admitted children presents with great clinical variability. When provided supportive care, patients with predominant respiratory symptoms without altered laboratory-test results generally have an uncomplicated course. Patients with complicated disease present mainly with fever and abdominal and/or mucocutaneous symptoms. Most develop shock. Elevation of inflammatory markers may allow for early detection and the final outcome is good.</p> </div></span><div class="kwd-group"> <div class="title" tagx="title" title="title">
Palabras clave</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd"><i>Shock</i></div> <div class="kwd" title="kwd">
NeumonÃ­a</div> <div class="kwd" title="kwd">
Coronavirus</div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd">
Shock</div> <div class="kwd" title="kwd">
Pneumonia</div> <div class="kwd" title="kwd">
Coronavirus</div> </div> </div> </div> <div class="body" title="body"> <div class="introducciÃ³n" title="sec"> <div class="title" tagx="title" title="title">
IntroducciÃ³n</div> <p id="par0005">En EspaÃ±a, el primer caso de coronavirus 2019 (COVID-19), causado por el nuevo coronavirus SARS-CoV-2<a href="#bib0180"><sup>1</sup></a>, fue detectado el 31 de enero de 2020. En las semanas siguientes, el SARS-CoV-2 se propagÃ³ por todo el paÃ­s, afectando mÃ¡s intensamente a la regiÃ³n de Madrid<a href="#bib0185"><sup>2</sup></a>.</p> <p id="par0010">Con el fin de optimizar los recursos sanitarios, a partir del 20 de marzo, la atenciÃ³n pediÃ¡trica urgente se centralizÃ³ en dos hospitales terciarios de la Comunidad AutÃ³noma. Estos dos centros se encargaron de proporcionar atenciÃ³n urgente, hospitalizaciÃ³n y cuidados intensivos a una poblaciÃ³n de aproximadamente 1.345.000 menores de 18 aÃ±os.</p> <p id="par0015">Aunque el SARS-CoV-2 puede infectar a personas de cualquier edad, la incidencia general de la infecciÃ³n entre los niÃ±os se ha estimado en un 1 a 2%<a href="#bib0190">3</a>, <a href="#bib0195">4</a>, <a href="#bib0200">5</a>. La prevalencia en niÃ±os en nuestro paÃ­s, segÃºn el estudio de seroprevalencia llevado a cabo en mayo de 2020 oscila entre el 1 y el 5%<a href="#bib0205"><sup>6</sup></a>. Los niÃ±os desarrollan formas de la enfermedad menos graves que los adultos y tienen en general mejor pronÃ³stico que Ã©stos<a href="#bib0210"><sup>7</sup></a>.</p> <p id="par0020">Los sÃ­ntomas mÃ¡s comÃºnmente descritos en los niÃ±os con infecciÃ³n por el SARS-CoV-2 se parecen a los observados en otras infecciones de las vÃ­as respiratorias superiores<a href="#bib0215"><sup>8</sup></a>, es decir, tos, fiebre, dolor de garganta, rinorrea y mialgias<a href="#bib0220"><sup>9</sup></a>. Los sÃ­ntomas gastrointestinales tambiÃ©n son frecuentes en esta poblaciÃ³n e incluyen hiporexia, nÃ¡useas, vÃ³mitos y diarrea. Se ha descrito en niÃ±os un sÃ­ndrome inflamatorio mÃºltiple con <i>shock</i> secundario a la infecciÃ³n por SARS-CoV-2, que puede cursar con fallo multiorgÃ¡nico, y se considera una de las formas mÃ¡s graves de la enfermedad en la poblaciÃ³n pediÃ¡trica<a href="#bib0225">10</a>, <a href="#bib0230">11</a>, <a href="#bib0235">12</a>. Esta forma clÃ­nica de la enfermedad habitualmente cursa con fiebre alta y sÃ­ntomas digestivos (en casi todos los casos con dolor abdominal intenso).</p> <p id="par0025">En el momento actual, no se ha categorizado bien el espectro de enfermedad por la infecciÃ³n SARS-CoV-2 en edad pediÃ¡trica. Faltan datos sobre el curso clÃ­nico y los marcadores de pronÃ³stico en los niÃ±os ingresados. En el presente trabajo se describen los datos epidemiolÃ³gicos, las diferentes formas de presentaciÃ³n clÃ­nica y los factores de riesgo de enfermedad complicada entre los niÃ±os hospitalizados con COVID-19.</p> </div> <div class="pacientesymÃ©todos" title="sec"> <div class="title" tagx="title" title="title">
Pacientes y mÃ©todos</div> <div class="poblaciÃ³ndelestudio" title="sec"> <div class="title" tagx="title" title="title">
PoblaciÃ³n del estudio</div> <p id="par0030">Se realizÃ³ un estudio observacional retrospectivo entre el 1 de marzo y el 30 de abril de 2020 en el Hospital Infantil Universitario NiÃ±o JesÃºs, que es un hospital terciario pediÃ¡trico de Madrid, EspaÃ±a. El comitÃ© de Ã©tica del hospital aprobÃ³ este estudio. Todos los datos se obtuvieron con el consentimiento de los padres o cuidadores.</p> <p id="par0035">Los criterios de inclusiÃ³n fueron los siguientes: </p><ul> <li><span class="label" tagx="label" title="label">-</span><p id="par0040">Pacientes menores de 18 aÃ±os de edad que requirieron ingreso a consecuencia de la infecciÃ³n por SARS-CoV-2.</p> </li> <li><span class="label" tagx="label" title="label">-</span><p id="par0215">InfecciÃ³n por SARS-CoV-2 confirmada utilizando la reacciÃ³n en cadena de la transcriptasa inversa-polimerasa (RT-PCR) en tiempo real en una muestra recogida con hisopo nasal y farÃ­ngeo o por la presencia de anticuerpos IgG en una muestra de sangre.</p> </li> </ul> <p /> <p id="par0050">Los criterios de exclusiÃ³n fueron los siguientes: </p><ul> <li><span class="label" tagx="label" title="label">-</span><p id="par0055">NiÃ±os con enfermedades oncolÃ³gicas.</p> </li> <li><span class="label" tagx="label" title="label">-</span><p id="par0060">Pacientes ingresados en los que se obtuvo PCR positiva para SARS-CoV-2, pero dicha infecciÃ³n no fue el motivo del ingreso.</p> </li> </ul> <p /> <p id="par0065">Los criterios para confirmar la infecciÃ³n por SARS-CoV-2 en los casos sospechosos variaron a lo largo de la pandemia. No se buscÃ³ la infecciÃ³n en los pacientes que no tenÃ­an criterios de ingreso. Antes del 11 de marzo, se realizÃ³ RT-PCR a los pacientes ingresados en el hospital si presentaban sÃ­ntomas de infecciÃ³n respiratoria aguda y habÃ­an viajado a zonas en las que se habÃ­an encontrado pruebas de transmisiÃ³n en la comunidad o si los pacientes habÃ­an estado en contacto estrecho con un caso probable o confirmado en los 14 dÃ­as anteriores. A partir del 11 de marzo se encontraron pruebas de propagaciÃ³n en la comunidad en la Comunidad AutÃ³noma, por lo que se solicitÃ³ RT-PCR a todos los pacientes ingresados con sÃ­ntomas compatibles con COVID-19. TambiÃ©n se buscÃ³ la infecciÃ³n en los niÃ±os que requerÃ­an cirugÃ­a urgente o que habÃ­an estado en contacto con casos confirmados o sospechosos de COVID-19 en el hogar y requerÃ­an ingreso, siendo estos casos excluidos del anÃ¡lisis en nuestro trabajo. La indicaciÃ³n para confirmar la infecciÃ³n fue valorada individualmente en los pacientes con una enfermedad de base. Las pruebas serolÃ³gicas estuvieron disponibles a finales de abril y se realizaron en muestras de sangre venosa. No se realizaron pruebas para confirmar la presencia de otros virus respiratorios de forma rutinaria. Se obtuvieron cultivos de sangre en caso de fiebre. Los criterios de ingreso fueron los mismos que se aplican habitualmente, segÃºn los protocolos habituales del centro para el manejo de cada entidad clÃ­nica, sin que Ã©stos se vieran influidos por la positividad de las pruebas para detectar la infecciÃ³n por SARS-CoV-2.</p> </div> <div class="definiciones" title="sec"> <div class="title" tagx="title" title="title">
Definiciones</div> <p id="par0070"> </p><ul> <li><span class="label" tagx="label" title="label">-</span><p id="par0075">Enfermedad complicada: necesidad de estabilizaciÃ³n hemodinÃ¡mica (infusiÃ³n de volumen o fÃ¡rmacos vasopresores) o de soporte respiratorio (cÃ¡nula nasal de alto flujo, ventilaciÃ³n no invasiva o ventilaciÃ³n mecÃ¡nica) o presencia de encefalopatÃ­a.</p> </li> <li><span class="label" tagx="label" title="label">-</span><p id="par0080">Enfermedad no complicada: pacientes que no requieren estabilizaciÃ³n hemodinÃ¡mica o asistencia respiratoria que no sea oxÃ­geno suplementario administrado a travÃ©s de una cÃ¡nula nasal o pacientes que no presentan encefalopatÃ­a.</p> </li> <li><span class="label" tagx="label" title="label">-</span><p id="par0085">Taquicardia: frecuencia cardÃ­aca superior al percentil 90 por grupo de edad y taquicardia extrema para las frecuencias cardÃ­acas superiores al percentil 99, segÃºn los valores de referencia<a href="#bib0240"><sup>13</sup></a>.</p> </li> </ul> <p /> </div> <div class="recopilaciÃ³ndedatos:procedimientosypruebascomplementarias" title="sec"> <div class="title" tagx="title" title="title">
RecopilaciÃ³n de datos: procedimientos y pruebas complementarias</div> <p id="par0090">Se obtuvieron datos epidemiolÃ³gicos, clÃ­nicos y de laboratorio en el momento del ingreso, hallazgos radiolÃ³gicos durante la estancia hospitalaria, asÃ­ como el tratamiento y la evoluciÃ³n. Estos datos se recopilaron a partir de las historias clÃ­nicas de los pacientes y mediante entrevista telefÃ³nica con los padres despuÃ©s del alta para reunir datos sobre las complicaciones y la evoluciÃ³n despuÃ©s del alta. La indicaciÃ³n de pruebas complementarias la decidiÃ³ el mÃ©dico responsable de cada paciente, siguiendo los protocolos habituales previos a la pandemia.</p> </div> <div class="pruebasdeimagen" title="sec"> <div class="title" tagx="title" title="title">
Pruebas de imagen</div> <p id="par0095">Se realizÃ³ una radiografÃ­a de tÃ³rax en caso de sospecha de neumonÃ­a, basada en los hallazgos clÃ­nicos.</p> <p id="par0100">Se indicÃ³ ecografÃ­a abdominal en caso de sospecha de abdomen agudo o en pacientes que presentaban inestabilidad hemodinÃ¡mica con dolor abdominal asociado.</p> <p id="par0105">Los resultados de todas las pruebas radiolÃ³gicas fueron interpretados por un radiÃ³logo pediÃ¡trico.</p> </div> <div class="anÃ¡lisisestadÃ­stico" title="sec"> <div class="title" tagx="title" title="title">
AnÃ¡lisis estadÃ­stico</div> <p id="par0110">El anÃ¡lisis descriptivo de los resultados se llevÃ³ a cabo utilizando el software SPSSÂ© para Windows (versiÃ³n 20.0). Se utilizaron la mediana y el rango intercuartÃ­lico para los datos cuantitativos. Para los datos cualitativos se utilizaron el porcentaje, el rango y el rango intercuartil. Se utilizÃ³ la prueba U de Mann-Whitney para comparar las variables continuas, y se considerÃ³ la significaciÃ³n estadÃ­stica cuando Î± fue inferior a 0,05.</p> </div> </div> <div class="resultados" title="sec"> <div class="title" tagx="title" title="title">
Resultados</div> <p id="par0115">Durante el perÃ­odo de estudio, 880 pacientes fueron ingresados en el hospital. En 551 se realizÃ³ RT-PCR para SARS-CoV-2 en frotis nasofarÃ­ngeo; 52 tuvieron un resultado positivo. Cinco pacientes con resultado negativo en la RT-PCR y una presentaciÃ³n clÃ­nica muy sugestiva de COVID-19 tenÃ­an anticuerpos Ig G detectables frente al SARS-CoV-2. Once pacientes fueron excluidos porque el motivo de ingreso no estaba directamente relacionado con la infecciÃ³n por el SARS-CoV-2; todos eran asintomÃ¡ticos o presentaban sÃ­ntomas respiratorios o gastrointestinales leves. Siete pacientes en tratamiento con quimioterapia fueron excluidos. Finalmente, se analizaron 39 pacientes para este estudio (<a href="#fig0005">fig. 1</a> ). </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figura 1</span></a></div>   <p>Pacientes incluidos en el estudio.</p>   </div> <p /> <div class="caracterÃ­sticasepidemiolÃ³gicas" title="sec"> <div class="title" tagx="title" title="title">
CaracterÃ­sticas epidemiolÃ³gicas</div> <p id="par0120">La mediana de era de edad nueve aÃ±os (rango: 12 dÃ­as-16 aÃ±os); 12 (31%) tenÃ­an menos de un aÃ±o de edad, cinco (13%) tenÃ­an entre uno y cinco aÃ±os de edad, nueve (23%) tenÃ­an entre seis y 10 aÃ±os, y 13 (33%) eran mayores de 10 aÃ±os; 23 (59%) eran varones; 27 pacientes (69%) tuvieron contacto en el hogar con un caso confirmado (siete) o sospechado (20) de COVID-19. En 12 niÃ±os se desconocÃ­a la posible exposiciÃ³n.</p> </div> <div class="caracterÃ­sticasclÃ­nicasyanalÃ­ticas,cursonocomplicadoversuscursocomplicado" title="sec"> <div class="title" tagx="title" title="title">
CaracterÃ­sticas clÃ­nicas y analÃ­ticas, curso no complicado versus curso complicado</div> <p id="par0130">Se utilizÃ³ un diagnÃ³stico sindrÃ³mico para clasificar a los pacientes incluidos. Se encontrÃ³ que 24 pacientes tenÃ­an una enfermedad no complicada (<a href="#tbl0005">tabla 1</a> ) y 15 una enfermedad complicada (<a href="#tbl0010">tabla 2</a> ). Los cinco pacientes que tenÃ­an una enfermedad subyacente desarrollaron una enfermedad no complicada. La mayorÃ­a de los niÃ±os con enfermedad complicada mostraron alteraciÃ³n en la apariencia (10/15) y taquicardia extrema (10/15) en la evaluaciÃ³n inicial en el servicio de urgencias (SU). La saturaciÃ³n de oxÃ­geno &amp;lt; 94% fue poco frecuente en ambos grupos. Las caracterÃ­sticas clÃ­nicas de todos los casos se resumen en la <a href="#tbl0015">tabla 3</a> . <div class="table-wrap_UNKNOWN" position="float" id="tbl0005"><span class="label" tagx="label" title="label">Tabla 1</span> </div></p><p>CaracterÃ­sticas epidemiolÃ³gicas, hallazgos clÃ­nicos y tratamiento de los pacientes ingresados con enfermedad no complicada</p>  <div tag="alt-text">
Tabla 1</div> <table frame="hsides" rules="groups"> <thead> <tr> <th align="left">DiagnÃ³stico sindrÃ³mico</th> <th align="left">N<br /><br />(total: 24)</th> <th align="left">Edad<br /><br />Mediana<br /><br />(rango)</th> <th align="left">Comorbilidad<br /><br />(No. /total)</th> <th align="left">Signos y<br /><br />sÃ­ntomas en el SU<br /><br />(No./total)</th> <th align="left">Rx de tÃ³rax en el SU<br /><br />(No./total)</th> <th align="left">Alteraciones analÃ­ticas<br /><br />(No./total)</th> <th align="left">CoinfecciÃ³n<br /><br />(No.)</th> <th align="left">Tratamiento de soporte<br /><br />(No. /total No.)</th> <th align="left">Tratamiento farmacolÃ³gico<br /><br />(No. /total)</th> <th align="left">DÃ­as de estancia<br /><br />Mediana<br /><br />(rango)</th> </tr> </thead> <tbody> <tr> <td align="left">Bronquiolitis</td> <td align="left">5</td> <td align="left">27 dÃ­as (12-46)</td> <td align="left">Ninguna</td> <td align="left">Dificultad respiratoria (5/5)<br /><br />Fiebre (4/5)<br /><br />Tos (3/5)<br /><br />Rechazo de la alimentaciÃ³n (3/5)</td> <td align="left">No realizada (3/5)<br /><br />Normal (2/5)<br /><br /></td> <td align="left">Linfopenia (1/3)<br /><br />â†‘LDH (1/1)</td> <td align="left"><i>B. Pertussis</i> (1)</td> <td align="left">OxÃ­geno (4/5)<br /><br /></td> <td align="left">Azitromicina (1/5)</td> <td align="left">3 (2-7)</td> </tr> <tr> <td align="left">Fiebre sin foco</td> <td align="left">3</td> <td align="left">24 dÃ­as (23-35)</td> <td align="left">Ninguna</td> <td align="left">Fiebre (3/3)</td> <td align="left">No realizada (3/3)</td> <td align="left">Normal (3/3)</td> <td align="left">No</td> <td align="left">No</td> <td align="left">No</td> <td align="left">3 (3-4)</td> </tr> <tr> <td align="left">NeumonÃ­a (no complicada)</td> <td align="left">7</td> <td align="left">4 aÃ±os (1-12)</td> <td align="left">Bronquiolitis obliterante (1/7)</td> <td align="left">Fiebre (7/7)<br /><br />Tos (5/7)<br /><br />Dificultad respiratoria (5/7)<br /><br />VÃ³mitos (4/7)<br /><br /></td> <td align="left">Infiltrado intersticial bilateral (3/7)<br /><br />ConsolidaciÃ³n unilateral (2/7)<br /><br />Infiltrado intersticial unilateral (1/7)<br /><br />Normal (1/7)<a href="#tblfn0005">**</a></td> <td align="left">Linfopenia (1/7)<br /><br />â†‘PCR (3/7)<br /><br />â†‘DD (3/3)<br /><br />â†‘LDH (3/4)<br /><br />â†‘PCT (1/4)<br /><br /></td> <td align="left">Micoplasma (1)<br /><br />Sospecha de coinfecciÃ³n bacteriana (3)</td> <td align="left">OxÃ­geno (4/7)<br /><br /></td> <td align="left">Azitromicina (6/7)<br /><br />AntibiÃ³tico (4/7)<br /><br />Corticosteroides (2/7)<br /><br />Salbutamol (3/7)</td> <td align="left">4 (2-8)</td> </tr> <tr> <td align="left">InfecciÃ³n respiratoria del tracto superior</td> <td align="left">7</td> <td align="left">12 aÃ±os (0-16)</td> <td align="left">Artritis juvenil idiopÃ¡tica (1/7)<br /><br />Aplasia medular (1/7)<br /><br />Anemia hemolÃ­tica (1/7)</td> <td align="left">Fiebre (6/7)<br /><br />Fiebre &amp;gt; 7 dÃ­as (2/7)<br /><br />Tos (4/7)<br /><br />Odinofagia (2/7)</td> <td align="left">Normal (6/7)<br /><br />No realizada (1/7)</td> <td align="left">Linfopenia (2/7)</td> <td align="left">No</td> <td align="left">OxÃ­geno (1/7)</td> <td align="left">Azitromicina (3/7) AntibiÃ³tico (4/7)<br /><br />Hidroxicloroquina (1/7)<br /><br /></td> <td align="left">2 (1-4)</td> </tr> <tr> <td align="left">Diarrea prolongada</td> <td align="left">1</td> <td align="left">54 dÃ­as</td> <td align="left">Alergia a proteÃ­na de leche de vaca</td> <td align="left">Diarrea<br /><br />VÃ³mitos DeshidrataciÃ³n</td> <td align="left">No realizada</td> <td align="left">Normal</td> <td align="left">No</td> <td align="left">RehidrataciÃ³n</td> <td align="left">FÃ³rmula elemental</td> <td align="left">3</td> </tr> <tr> <td align="left">Dolor abdominal</td> <td align="left">1</td> <td align="left">12 aÃ±os</td> <td align="left">Ninguna</td> <td align="left">Dolor abdominal</td> <td align="left">No realizada</td> <td align="left">Normal</td> <td align="left">No</td> <td align="left">No</td> <td align="left">AnalgÃ©sicos</td> <td align="left">3</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>PCR = proteÃ­na C reactiva. PCT= procalcitonina. DD = dÃ­mero D. LDH = lactato deshidrogenasa, Rx = radiografÃ­a. SatO<sub>2</sub> = saturaciÃ³n de oxÃ­geno. SU = Servicio de Urgencias.</p> </div> <div class="fn-type-" title=""> <p>*AlteraciÃ³n analÃ­tica: considerada si PCR â‰¥ 5 mg/dL, PCT â‰¥ 2 ng/mL, DD â‰¥ 500 ng/mL, ferritina â‰¥ 500 ng/mL, LDH â‰¥ 300 U/L y linfocitos &amp;lt; 1.000 x 10<sup>9</sup>/L</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">**</span><p id="npar0005">1 paciente que tenÃ­a Rx de tÃ³rax normal al ingreso desarrollÃ³ una neumonÃ­a con consolidaciÃ³n unilateral posteriormente.</p> </div> </div>  <div class="table-wrap_UNKNOWN" position="float" id="tbl0010"><span class="label" tagx="label" title="label">Tabla 2</span> <p>CaracterÃ­sticas epidemiolÃ³gicas, clÃ­nicas y evoluciÃ³n de los pacientes ingresados con enfermedad complicada</p>  <div tag="alt-text">
Tabla 2</div> <table frame="hsides" rules="groups"> <thead> <tr> <th align="left">DiagnÃ³stico sindrÃ³mico</th> <th align="left">N<br /><br />(total: 15)</th> <th align="left">Edad mediana (rango)</th> <th align="left">Comorbilidades<br /><br />(No./total)</th> <th align="left">Signos y sÃ­ntomas en el SU (No./total)</th> <th align="left">Rx de tÃ³rax en el SU<br /><br />(No./total)</th> <th align="left">Alteraciones analÃ­ticas<a href="#tblfn0010">*</a><br /><br />(No./total)</th> <th align="left">CoinfecciÃ³n<br /><br />(No.)</th> <th align="left">Tratamiento de soporte<br /><br />(No./total)<br /><br /></th> <th align="left">Tratamiento farmacolÃ³gico<br /><br />(No./total)</th> <th align="left">DÃ­as de estancia mediana (rango)</th> <th align="left">Complicaciones</th> </tr> </thead> <tbody> <tr> <td align="left"><i>Shock</i></td> <td align="left">12<a href="#tblfn0015">**</a></td> <td align="left">10 aÃ±os (6-14)</td> <td align="left">Ninguna</td> <td align="left">Fiebre (12/12)<br /><br />Dolor abdominal (11/12)<br /><br />Diarrea (10/12)<br /><br />Taquicardia extrema (9/12)<br /><br />Apariencia alterada (8/12)<br /><br />Exantema (8/12)<br /><br />Hiperemia conjuntival (7/12)<br /><br />VÃ³mitos (6/12)<br /><br />Tos (6/12)</td> <td align="left">Normal (6/12)<a href="#tblfn0020">***</a><br /><br />ConsolidaciÃ³n bilateral (2/12)<br /><br />Infiltrado intersticial bilateral (2/12)<br /><br />Infiltrado intersticial bilateral con consolidaciÃ³n unilateral (1/12)<br /><br />ConsolidaciÃ³n unilateral (1/12)</td> <td align="left">â†‘PCR (12/12)<br /><br />Linfopenia (10/12)<br /><br />â†‘PCT (10/12)<br /><br />â†‘DD (12/12)<br /><br />â†‘LDH (8/12)<br /><br />â†‘ferritina (7/11)</td> <td align="left">Micoplasma (1)<br /><br />VHH-6 (1)</td> <td align="left">UCIP (11/12)<br /><br />OAF (10/12)<br /><br />VM (2/12)<br /><br />Vasopresores (8/12)<br /><br />Hemoderivados (2/12)</td> <td align="left">AntibiÃ³tico (12/12)<br /><br />Hidroxicloroquina (11/12)<br /><br />Heparina (11/12)<br /><br />LPV/RTV (10/12)<br /><br />Azitromicina (9/12)<br /><br />Corticosteroides (11/12)<br /><br />Tocilizumab (6/12)<br /><br />Immunoglobulinas (4/12)<br /><br /></td> <td align="left">10 (5-22)</td> <td align="left">DisfunciÃ³n miocÃ¡rdica aguda (4/12)<br /><br />SÃ­ndrome de distrÃ©s respiratorio agudo (3/12)<br /><br />Fallo renal agudo (2/12)<br /><br />Encefalitis (1/12)</td> </tr> <tr> <td align="left">Apnea-bronquiolitis</td> <td align="left">1</td> <td align="left">16 dÃ­as</td> <td align="left">Ninguna</td> <td align="left">Dificultad respiratoria<br /><br />Tos<br /><br />Rechazo de la alimentaciÃ³n<br /><br />Apnea</td> <td align="left">Normal</td> <td align="left">â†‘DD</td> <td align="left">InfecciÃ³n del tracto urinario nosocomial (<i>Klebsiella pneumoniae</i>)</td> <td align="left">UCIP<br /><br />VNI<br /><br /><br /><br /></td> <td align="left">Azitromicina<br /><br />AntibiÃ³tico<br /><br />Hidroxicloroquina LPV/RTV<br /><br />CafeÃ­na</td> <td align="left">16</td> <td /> </tr> <tr> <td align="left">NeumonÃ­a complicada</td> <td align="left">1</td> <td align="left">7 meses</td> <td align="left">Ninguna</td> <td align="left">Mal estado general<br /><br />Taquicardia extrema Fiebre<br /><br />Dificultad respiratoria<br /><br />Tos<br /><br />Rechazo de la alimentaciÃ³n</td> <td align="left">ConsolidaciÃ³n unilateral, derrame pleural (1)</td> <td align="left">â†‘PCR<br /><br />â†‘PCT<br /><br />â†‘DD</td> <td align="left"><i>Streptococcus pneumoniae</i></td> <td align="left">UCIP<br /><br />VNI<br /><br />Hemoderivados Drenaje pleural</td> <td align="left">Azitromicina<br /><br />AntibiÃ³tico<br /><br />Hidroxicloroquina LPV/RTV<br /><br />Corticosteroides</td> <td align="left">18</td> <td align="left">NeumonÃ­a necrotizante<br /><br /></td> </tr> <tr> <td align="left">Trombosis mÃºltiple</td> <td align="left">1</td> <td align="left">13 aÃ±os</td> <td align="left">Ninguna</td> <td align="left">Mal estado general<br /><br />Bradicardia<br /><br />Fiebre<br /><br />VÃ³mitos<br /><br />Cefalea<br /><br />Somnoliencia</td> <td align="left">Normal <a href="#tblfn0025">****</a></td> <td align="left">â†‘PCR<br /><br />â†‘DD</td> <td align="left">No</td> <td align="left">UCIP<br /><br />OxÃ­geno<br /><br />Hemoderivados</td> <td align="left">Azitromicina<br /><br />AntibiÃ³tico<br /><br />Hidroxicloroquina LPV/RTV<br /><br />Corticosteroides<br /><br />Heparina</td> <td align="left">23</td> <td align="left">Trombosis de senos venosos<br /><br />HipertensiÃ³n intracraneal<br /><br />Tromboembolismo pulmonar<br /><br />Trombosis venosa profunda</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>DD = dÃ­mero D. LDH = lactato deshidrogenasa. LPV/RTV = lopinavir/ritonavir. OAF = oxigenoterapia de alto flujo. PCR= proteÃ­na C reactiva. PCT = procalcitonina. Rx = radiografÃ­a. SatO<sub>2</sub> = saturaciÃ³n de oxÃ­geno. SU: Servicio de Urgencias. UCIP = unidad de cuidados intensivos pediÃ¡tricos. VM = ventilaciÃ³n mecÃ¡nica con intubaciÃ³n endotraqueal. VNI = ventilaciÃ³n no invasiva.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">*</span><p id="npar0010">Alteraciones analÃ­ticas: cuando PCR â‰¥ 5 mg/dL, PCT â‰¥ 2 ng/mL, DD â‰¥ 500 ng/mL, ferritina â‰¥ 500 ng/mL, LDH â‰¥ 300 U/L y linfocitos &amp;lt; 1.000 x 10<sup>9</sup>/L.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">**</span><p id="npar0015">Cinco pacientes tuvieron test de RT-PCR negativa para SARS-CoV-2, pero serologÃ­a IgG positiva.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">***</span><p id="npar0020">Seis pacientes tuvieron Rx de tÃ³rax normal al ingreso; dos de ellos desarrollaron un infiltrado intersticial con consolidaciones durante el ingreso.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">****</span><p id="npar0025">DesarrollÃ³ infiltrados intersticiales biletarales con consolidaciÃ³n unilateral durante el ingreso.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" position="float" id="tbl0015"><span class="label" tagx="label" title="label">Tabla 3</span> <p>CaracterÃ­sticas epidemiolÃ³gicas y clÃ­nicas de los pacientes</p>  <div tag="alt-text">
Tabla 3</div> <table frame="hsides" rules="groups"> <thead> <tr> <th align="left">CaracterÃ­sticas</th> <th align="left">Enfermedad no complicada<br /><br />(n = 24)</th> <th align="left">Enfermedad complicada<br /><br />(n = 15)</th> <th align="left">Total<br /><br />(n = 39)</th> </tr> </thead> <tbody> <tr> <td align="left">Edad mediana aÃ±os (rango)</td> <td align="left">2,5 (12 dÃ­as â€" 16 aÃ±os)</td> <td align="left">9,4 (16 dÃ­as â€" 14 aÃ±os)</td> <td align="left">9,0 (12 dÃ­as -16 aÃ±os)</td> </tr> <tr> <td colspan="4" align="left"><i>Edad distribuciÃ³n â€" no. (%)</i></td> </tr> <tr> <td align="left">Â &amp;lt; 1 aÃ±o</td> <td align="left">10/24 (41,6)</td> <td align="left">2/15 (13,3)</td> <td align="left">12/39 (30,7)</td> </tr> <tr> <td align="left">Â 1 a &amp;lt; 6 aÃ±os</td> <td align="left">4/24 (16,6)</td> <td align="left">1/15 (6,6)</td> <td align="left">5/39 (12,8)</td> </tr> <tr> <td align="left">Â 6-10 aÃ±os</td> <td align="left">3/24 (12,5)</td> <td align="left">6/15 (40,0)</td> <td align="left">9/39 (23,0)</td> </tr> <tr> <td align="left">Â &amp;gt; 10 aÃ±os</td> <td align="left">7/24 (29,1)</td> <td align="left">6/15 (40,0)</td> <td align="left">13/39 (33,3)</td> </tr> <tr> <td colspan="4" align="left"><i>Sexo --- no. (%)</i></td> </tr> <tr> <td align="left">Â Femenino</td> <td align="left">10/24 (41,6)</td> <td align="left">6/15 (40,0)</td> <td align="left">16/39 (41,0)</td> </tr> <tr> <td align="left">Â Masculino</td> <td align="left">14/24 (58,3)</td> <td align="left">9/15 (60,0)</td> <td align="left">23/39 (58,9)</td> </tr> <tr> <td align="left">Comorbilidades â€" no. (%)</td> <td align="left">5/24 (20,8)</td> <td align="left">0/15 (0/0)</td> <td align="left">5/39 (12,8)</td> </tr> <tr> <td colspan="4" align="left"><i>SÃ­ntomas en el SU -- no. (%)</i></td> </tr> <tr> <td align="left">Â Fiebre â‰¥ 38Â Â°C</td> <td align="left">18/24 (75,0)</td> <td align="left">14/15 (93,3)</td> <td align="left">32/39 (82,0)</td> </tr> <tr> <td align="left">Â Tos</td> <td align="left">12/24 (50,0)</td> <td align="left">8/15 (53,3)</td> <td align="left">20/39 (51,2)</td> </tr> <tr> <td align="left">Â Dificultad respiratoria</td> <td align="left">13/24 (54,1)</td> <td align="left">4/15 (26,6)</td> <td align="left">17/39 (43,5)</td> </tr> <tr> <td align="left">Â Rinorrea</td> <td align="left">12/24 (50,0)</td> <td align="left">2/15 (13,3)</td> <td align="left">14/39 (35,8)</td> </tr> <tr> <td align="left">Â Rechazo de la alimentaciÃ³n</td> <td align="left">7/24 (29,1)</td> <td align="left">5/15 (33,3)</td> <td align="left">12/39 (30,7)</td> </tr> <tr> <td align="left">Â Somnolencia</td> <td align="left">0/24 (0)</td> <td align="left">1/15 (6,6)</td> <td align="left">1/39 (2,6)</td> </tr> <tr> <td align="left">Â NÃ¡usea o vÃ³mitos</td> <td align="left">7/24 (29,1)</td> <td align="left">8/15 (53,3)</td> <td align="left">15/39 (38,4)</td> </tr> <tr> <td align="left">Â Diarrea</td> <td align="left">4/24 (16,6)</td> <td align="left">10/15 (66,6)</td> <td align="left">14/39 (35,8)</td> </tr> <tr> <td align="left">Â Dolor abdominal</td> <td align="left">1/24 4,1)</td> <td align="left">11/15 (73,3)</td> <td align="left">12/39 (30,7)</td> </tr> <tr> <td align="left">Â Cefalea</td> <td align="left">3/24 (12,5)</td> <td align="left">5/15 (33,3)</td> <td align="left">7/39 (17,9)</td> </tr> <tr> <td align="left">Â Odinofagia</td> <td align="left">2/24 (8,3)</td> <td align="left">2/15 (13,3)</td> <td align="left">4/39 (10,2)</td> </tr> <tr> <td align="left">Â Exantema</td> <td align="left">2/24 (8,3)</td> <td align="left">8/15 (53,3)</td> <td align="left">10/39 (25,6)</td> </tr> <tr> <td align="left">Â Hiperemia conjuntival</td> <td align="left">0/24 (8,3)</td> <td align="left">7/15 (46,6)</td> <td align="left">7/39 (17,9)</td> </tr> <tr> <td align="left">Â Apnea</td> <td align="left">0/24 (0)</td> <td align="left">1/15 (6.6)</td> <td align="left">1/39 (2,6)</td> </tr> <tr> <td align="left">Â Disnea</td> <td align="left">3/24 (12,5)</td> <td align="left">6/15 (40,0)</td> <td align="left">9/39 (23,0)</td> </tr> <tr> <td colspan="4" align="left"><i>Signos en el SU -- no. (%)</i></td> </tr> <tr> <td align="left">Â Apariencia alterada</td> <td align="left">0/24 (0)</td> <td align="left">10/15 (66,6)</td> <td align="left">10/39 (25,6)</td> </tr> <tr> <td align="left">Â Taquicardia</td> <td align="left">6/24 (25,0)</td> <td align="left">13/15 (86,6)</td> <td align="left">19/39 (48,7)</td> </tr> <tr> <td align="left">Â Frecuencia cardÃ­aca p90-p99</td> <td align="left">5/24 (20,8)</td> <td align="left">3/15 (20,0)</td> <td align="left">8/39 (20,5)</td> </tr> <tr> <td align="left">Â Frecuencia cardÃ­aca â‰¥ p99</td> <td align="left">1/24 (4,1)</td> <td align="left">10/15 (66,6)</td> <td align="left">11/39 (28,2)</td> </tr> <tr> <td align="left">Â SaturaciÃ³n de oxÃ­geno &amp;lt; 94%</td> <td align="left">4/24 (16,6)</td> <td align="left">2/15 (13,3)</td> <td align="left">6/39 (15,4)</td> </tr> <tr> <td align="left">Â Dificultad respiratoria</td> <td align="left">10/24 (41,6)</td> <td align="left">10/15 (66,6)</td> <td align="left">20/39 (51,3)</td> </tr> <tr> <td colspan="4" align="left"><i>Imagen - no./total (%)</i></td> </tr> <tr> <td align="left">Â Rx de tÃ³rax en el SU</td> <td align="left">15/24 (62,5)</td> <td align="left">15/15 (100)</td> <td align="left">30/39 (76,9)</td> </tr> <tr> <td align="left">Â Resultado normal</td> <td align="left">9/15 (60,0)</td> <td align="left">8/15 (53,3)</td> <td align="left">17/30 (56,6)</td> </tr> <tr> <td align="left">Â TC torÃ¡cico</td> <td align="left">0/24 (0)</td> <td align="left">3/15 (20,0)</td> <td align="left">3/39 (7,7)</td> </tr> <tr> <td align="left">Â EcografÃ­a abdominal</td> <td align="left">2/24 (8,3)</td> <td align="left">10/15 (66,6)</td> <td align="left">12/39 (30,7)</td> </tr> <tr> <td colspan="4" align="left"><i>Pruebas diagnÃ³sticas no. /total (%)</i></td> </tr> <tr> <td align="left">Â RT-PCR para SARS-CoV-2</td> <td align="left">24/24 (100)</td> <td align="left">15/15 (100)</td> <td align="left">39/39 (100)</td> </tr> <tr> <td align="left">Â RT-PCR positiva</td> <td align="left">24/24 (100)</td> <td align="left">10/15 (66,6)</td> <td align="left">34/39 (87,1)</td> </tr> <tr> <td align="left">Â Pacientes con PCR positiva y PCR negativa previa</td> <td align="left">1/24 (4,1)</td> <td align="left">3/10 (30)</td> <td align="left">4/34 (11,7)</td> </tr> <tr> <td align="left">Â SerologÃ­a</td> <td align="left">0/24 (0)</td> <td align="left">5/15 (33,3)</td> <td align="left">5/39 (12,8)</td> </tr> <tr> <td align="left">Â Ig G positiva</td> <td align="left">NA</td> <td align="left">5/5 (100)</td> <td align="left">5/5 (100)</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>RT-PCR = reacciÃ³n en cadena de la transcriptasa inversa-polimerasa en tiempo real. Rx = radiografÃ­a. SatO<sub>2</sub> = saturaciÃ³n de oxÃ­geno. SU = Servicio de Urgencias. TC = tomografÃ­a computarizada.</p> </div> </div> </div> <p /> <p id="par0135">Las pruebas de laboratorio y los resultados de los biomarcadores se resumen y comparan en la <a href="#tbl0020">tabla 4</a> . Encontramos una diferencia significativa entre ambos grupos en tÃ©rminos de recuento de linfocitos, nivel de proteÃ­na C reactiva, procalcitonina, ferritina y dÃ­mero D. AdemÃ¡s, la proporciÃ³n de neutrÃ³filos/linfocitos fue mayor entre los pacientes con enfermedad complicada (p = 0,001). <div class="table-wrap_UNKNOWN" position="float" id="tbl0020"><span class="label" tagx="label" title="label">Tabla 4</span> </div></p><p>Alteraciones analÃ­ticas en el SU</p>  <div tag="alt-text">
Tabla 4</div> <table frame="hsides" rules="groups"> <thead> <tr> <th align="left">Alteraciones analÃ­ticas en el SU</th> <th align="left">Enfermedad no complicada (N=24)</th> <th align="left">Enfermedad complicada (N=15)</th> <th align="left">Valor de p</th> </tr> </thead> <tbody> <tr> <td align="left">Leucocitos x 10<sup>9</sup>/L mediana (RIQ)</td> <td align="left">8.510 (5.000-12.240)</td> <td align="left">8.060 (7.530-10.300)</td> <td align="left">P = 0,51</td> </tr> <tr> <td align="left">NeutrÃ³filos x 10<sup>9</sup>/L mediana (RIQ)</td> <td align="left">3.420 (2.340-5.650)</td> <td align="left">6.720 (6.200-9.400)</td> <td align="left">P = 0,009</td> </tr> <tr> <td align="left">Linfocitos x 10<sup>9</sup>/L mediana (RIQ)</td> <td align="left">2.705 (1.470-4.470)</td> <td align="left">750 (350-1.800)</td> <td align="left">P = 0,001</td> </tr> <tr> <td align="left">ProporciÃ³n neutrÃ³filos/linfocitos</td> <td align="left">1,34</td> <td align="left">12,62</td> <td align="left">P = 0,001</td> </tr> <tr> <td align="left">PCR mg/dL mediana (RIQ)</td> <td align="left">0,5 (0,2-1,7)</td> <td align="left">20,6 (15,3-34,2)</td> <td align="left">P &amp;lt; 0,001</td> </tr> <tr> <td align="left">PCT ng/mL mediana (RIQ)</td> <td align="left">0,10 (0,02-0,21)</td> <td align="left">5,73 (1,77-14,08)</td> <td align="left">P = 0,001</td> </tr> <tr> <td align="left">DÃ­mero D ng/mL mediana (RIQ)</td> <td align="left">490 (230-630)</td> <td align="left">3.960 (2.210-6.660)</td> <td align="left">P &amp;lt; 0,001</td> </tr> <tr> <td align="left">LDH U/L mediana (RIQ)</td> <td align="left">285 (203-347)</td> <td align="left">305 (272-348)</td> <td align="left">P = 0,27</td> </tr> <tr> <td align="left">Ferritina ng/mL mediana (RIQ)</td> <td align="left">77 (20-194)</td> <td align="left">686 (255-1.392)</td> <td align="left">P &amp;lt; 0,001</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>PCR = proteÃ­na C reactiva. PCT = procalcitonina. DD = dÃ­mero D. LDH = lactato deshidrogenasa. RIQ = rango intercuartÃ­lico.</p> </div> </div>  <p /> <p id="par0140">Se realizÃ³ una radiografÃ­a de tÃ³rax en el SU a 30 pacientes, de las cuales 13 presentaron alteraciones (<a href="#tbl0015">tabla 3</a>). Durante el ingreso, otros cuatro pacientes desarrollaron neumonÃ­a.</p> <p id="par0145">Se realizÃ³ una ecografÃ­a abdominal a 12 pacientes; los hallazgos mÃ¡s frecuentes fueron la inflamaciÃ³n de la pared intestinal (4/12) y la presencia de lÃ­quido libre (4/12). Tres pacientes tuvieron una ecografÃ­a normal.</p> </div> <div class="cursoclÃ­nicoeingresoencuidadosintensivospediÃ¡tricos" title="sec"> <div class="title" tagx="title" title="title">
Curso clÃ­nico e ingreso en cuidados intensivos pediÃ¡tricos</div> <p id="par0150">Catorce pacientes (36%) requirieron ingreso en la unidad de cuidados intensivos pediÃ¡tricos (UCIP): 10 directamente desde el SU y 4 desde la planta de hospitalizaciÃ³n (todos en las primeras 36 horas desde su ingreso). Durante las primeras cinco semanas del perÃ­odo de estudio, tres pacientes fueron admitidos en la UCIP con sÃ­ntomas neurolÃ³gicos o respiratorios (uno trombosis mÃºltiple, uno apnea, uno neumonÃ­a neumocÃ³cica). En las dos semanas siguientes, 11 niÃ±os requirieron cuidados en la UCIP con sospecha de un cuadro de respuesta inflamatoria sistÃ©mica pediÃ¡trico temporalmente asociado a COVID-19, la mayorÃ­a presentando sÃ­ntomas abdominales y <i>shock</i>.</p> <p id="par0155">La mediana de estancia en el hospital fue de cuatro dÃ­as (rango 1-23) y de estancia en la UCIP fue de cinco dÃ­as (rango 2-21). Todos los niÃ±os fueron dados de alta sin secuelas aparentes y ninguno de ellos desarrollÃ³ complicaciones despuÃ©s del alta.</p> </div> </div> <div class="discusiÃ³n" title="sec"> <div class="title" tagx="title" title="title">
DiscusiÃ³n</div> <p id="par0160">A pesar de la propagaciÃ³n mundial de la COVID-19, el espectro clÃ­nico en los niÃ±os sigue sin estar aclarado. AÃºn no se conoce completamente el papel que juegan los niÃ±os en la transmisiÃ³n de la enfermedad y el mecanismo de infecciÃ³n infantil. La agrupaciÃ³n de casos en familias se ha descrito en varios trabajos<a href="#bib0210">7</a>, <a href="#bib0215">8</a>, <a href="#bib0225">10</a>, <a href="#bib0245">14</a>, <a href="#bib0250">15</a> y parece que los niÃ±os son los mÃ¡s comÃºnmente infectados por los adultos, probablemente como resultado de las medidas de confinamiento aplicadas para frenar la propagaciÃ³n del virus. En nuestro estudio, la mayorÃ­a de los niÃ±os (70%) tuvieron una exposiciÃ³n previa a un adulto con COVID-19 confirmado o sospechado en el hogar, lo que sugiere que los niÃ±os no eran el caso Ã­ndice.</p> <p id="par0165">Se ha afirmado que la COVID-19 es mÃ¡s leve y menos frecuente en los niÃ±os que en los adultos<a href="#bib0255">16</a>, <a href="#bib0260">17</a>, <a href="#bib0265">18</a>, <a href="#bib0270">19</a>, <a href="#bib0275">20</a>. Durante el perÃ­odo de estudio, 57 niÃ±os con infecciÃ³n por SARS-CoV-2 fueron ingresados en uno de los dos hospitales de referencia para niÃ±os hospitalizados en la Comunidad AutÃ³noma de Madrid, aunque Ã©stos sÃ³lo representaron el 6,4% de los ingresos hospitalarios. En el mismo perÃ­odo, el nÃºmero total de adultos con COVID-19 ingresados en diferentes hospitales de la comunidad autÃ³noma superÃ³ los 40.000<a href="#bib0190"><sup>3</sup></a>. Esta disparidad apunta claramente a un curso de la enfermedad mÃ¡s leve y menos frecuente en los niÃ±os. En series anteriores, entre el 5 y el 67% de los niÃ±os infectados fueron hospitalizados<a href="#bib0195">4</a>, <a href="#bib0220">9</a>, <a href="#bib0245">14</a>. Se ha descrito que la hospitalizaciÃ³n es mÃ¡s comÃºn entre los pacientes pediÃ¡tricos menores de un aÃ±o de edad y los que tienen una enfermedad de base. En nuestra serie, 12 de los 39 pacientes eran menores de un aÃ±o (32% de los casos), cifra que es similar al 40% comunicado por Cantoni y a la tasa del 30% comunicada por Garazzino<a href="#bib0245"><sup>14</sup></a> en Italia, aunque un porcentaje mucho mÃ¡s alto que en China (18% en la serie Lu<a href="#bib0220"><sup>9</sup></a> y 11% en la de Dong<a href="#bib0215"><sup>8</sup></a>) y la tasa contenida en un informe de CDC (15%)<a href="#bib0280"><sup>21</sup></a>. La mayorÃ­a de los lactantes de nuestro hospital tuvieron una enfermedad no complicada, con la excepciÃ³n de un reciÃ©n nacido con apnea<a href="#bib0285"><sup>22</sup></a> y un lactante con neumonÃ­a neumocÃ³cica<a href="#bib0290"><sup>23</sup></a>. MÃ¡s de la mitad de los niÃ±os ingresados eran mayores de seis aÃ±os, y la edad media de los niÃ±os con <i>shock</i> fue de 10 aÃ±os. Se desconoce si los niÃ±os mayores tienen un mayor riesgo de desarrollar un sÃ­ndrome de respuesta inflamatoria sistÃ©mica temporalmente asociado a COVID-19.</p> <p id="par0170">Los criterios de hospitalizaciÃ³n pueden variar significativamente de un centro a otro. Los pacientes pueden ser ingresados como un medio preventivo de aislamiento, debido a su condiciÃ³n clÃ­nica (signos y sÃ­ntomas de mayor gravedad), o debido a la presencia de factores de riesgo para un curso complicado de la enfermedad. En nuestro hospital, los niÃ±os fueron ingresados principalmente debido a la gravedad de la enfermedad. Los criterios clÃ­nicos de ingreso que se aplicaron no diferÃ­an de los protocolos institucionales previamente establecidos para cada entidad nosolÃ³gica. La mayorÃ­a de los pacientes estaban previamente sanos, y no podemos descartar que aquellos con una condiciÃ³n subyacente tengan un mayor riesgo de deterioro.</p> <p id="par0175">La mayorÃ­a de nuestros pacientes presentaron fiebre (87%), lo cual fue mÃ¡s comÃºn que en los informes de China (71%)<a href="#bib0220"><sup>9</sup></a> e Italia (36%)<a href="#bib0250"><sup>15</sup></a>. Esto podrÃ­a estar relacionado con un sesgo de selecciÃ³n porque todos los niÃ±os incluidos en nuestra serie requirieron ingreso. En estos pacientes, la fiebre podrÃ­a ser una expresiÃ³n de una forma mÃ¡s grave de la enfermedad.</p> <p id="par0180">Los niÃ±os con enfermedad no complicada desarrollaron principalmente sÃ­ntomas respiratorios parecidos a un resfriado o una enfermedad similar a la gripe, bronquiolitis o neumonÃ­a. Algunos lactantes menores de tres meses de edad se presentaron con fiebre sin foco. Los sÃ­ntomas clÃ­nicos eran inespecÃ­ficos y pueden superponerse con otras infecciones respiratorias virales o bacterianas. No tuvieron alteraciones significativas en las pruebas de laboratorio, excepto la elevaciÃ³n aislada de la PCR en unos pocos casos. Los pacientes con enfermedad no complicada mejoraron con tratamiento de soporte y fueron dados de alta en pocos dÃ­as. La mayorÃ­a no recibiÃ³ ninguno de los medicamentos empÃ­ricos propuestos para el tratamiento de COVID-19<a href="#bib0220">9</a>, <a href="#bib0250">15</a>, <a href="#bib0295">24</a>, <a href="#bib0300">25</a>, <a href="#bib0305">26</a>, <a href="#bib0310">27</a>, <a href="#bib0315">28</a>.</p> <p id="par0185">Las infecciones respiratorias tambiÃ©n pueden provocar complicaciones mÃ¡s graves como la apnea (en niÃ±os muy pequeÃ±os), la coinfecciÃ³n bacteriana o la insuficiencia respiratoria. En nuestra serie, un neonato presentÃ³ apnea repetida y otro presentÃ³ sepsis neumocÃ³cica y neumonÃ­a con derrame pleural, desarrollando posteriormente una neumonÃ­a necrotizante. No estÃ¡ claro si el curso de la enfermedad en esta Ãºltima estaba relacionado sÃ³lo con la infecciÃ³n bacteriana o con ambas.</p> <p id="par0190">Es notable que despuÃ©s de las primeras cinco semanas de la epidemia observamos una nueva forma de presentaciÃ³n clÃ­nica<a href="#bib0225"><sup>10</sup></a>. Estos pacientes eran de mayor edad, tenÃ­an fiebre alta y referÃ­an sÃ­ntomas gastrointestinales significativos (dolor abdominal intenso, diarrea, vÃ³mitos) y/o erupciÃ³n y/o hiperemia conjuntival. Los sÃ­ntomas respiratorios eran menos frecuentes en estos casos. La mayorÃ­a se presentÃ³ en el servicio de urgencias con apariencia visiblemente alterada y taquicardia extrema. El sello distintivo de estos nuevos casos es el desarrollo de un <i>shock</i> en un corto perÃ­odo de tiempo desde la consulta en el SU<a href="#bib0320">29</a>, <a href="#bib0325">30</a>. Los pacientes recibieron soporte respiratorio y hemodinÃ¡mico en la UCIP y tratamiento con fÃ¡rmacos antivirales, hidroxicloroquina, antibiÃ³ticos y antiinflamatorios. Todos los hemocultivos fueron negativos. Esta entidad tiene caracterÃ­sticas clÃ­nicas en comÃºn con otras condiciones inflamatorias pediÃ¡tricas, incluyendo la enfermedad de Kawasaki, miocarditis, sÃ­ndromes de <i>shock</i> tÃ³xico, sepsis bacteriana o abdominal y sÃ­ndromes de activaciÃ³n de macrÃ³fagos<a href="#bib0230"><sup>11</sup></a>. Su reconocimiento precoz es crucial. Cabe destacar que estos pacientes presentaron una elevaciÃ³n significativa de los marcadores inflamatorios (proteÃ­na C reactiva, procalcitonina, dÃ­mero D, ferritina) y linfopenia, asÃ­ como una mayor proporciÃ³n de neutrÃ³filos/linfocitos. Esta relaciÃ³n se ha notificado como un biomarcador Ãºtil relacionado con el diagnÃ³stico de otras afecciones como la infecciÃ³n por el virus de la gripe y la sepsis<a href="#bib0330"><sup>31</sup></a>. Recientemente se ha publicado la asociaciÃ³n entre la elevaciÃ³n de esta proporciÃ³n y formas graves de la enfermedad en adultos, pero no hay datos al respecto en niÃ±os hasta el momento<a href="#bib0335"><sup>32</sup></a>. La LDH no parece ser un marcador analÃ­tico de gravedad en nuestros pacientes, lo que contrasta con los adultos<a href="#bib0340"><sup>33</sup></a>. TambiÃ©n es importante seÃ±alar que ocho de los 12 pacientes desarrollaron neumonÃ­a radiolÃ³gica aunque los sÃ­ntomas respiratorios no eran predominantes en el momento del ingreso<a href="#bib0345"><sup>34</sup></a>. Debido a los hallazgos clÃ­nicos y de laboratorio y a la agrupaciÃ³n de casos en un perÃ­odo fuera de los niveles mÃ¡ximos de la epidemia, formulamos la hipÃ³tesis de que la infecciÃ³n por SARS-CoV-2 puede desencadenar una respuesta inflamatoria que lleve al <i>shock</i>. Siete de estos pacientes dieron positivo en la prueba de SARS-CoV-2 con RT-PCR, pero sÃ³lo cinco dieron positivo en anticuerpos IgG, lo que sugiere que esta respuesta inflamatoria puede ocurrir durante el perÃ­odo agudo o despuÃ©s de que la infecciÃ³n haya pasado<a href="#bib0350"><sup>35</sup></a>.</p> <p id="par0195">Este estudio tiene varias limitaciones. Debido al pequeÃ±o tamaÃ±o de la muestra y al diseÃ±o retrospectivo utilizado, es necesario seguir investigando para confirmar estos hallazgos. Dado que sÃ³lo se analizaron en nuestro hospital aquellos pacientes que necesitaban hospitalizaciÃ³n o que tenÃ­an factores de riesgo de padecer una enfermedad grave, los datos presentados aquÃ­ no reflejan la incidencia total de COVID-19 en niÃ±os y no pueden compararse con algunas series publicadas anteriormente. AdemÃ¡s, realizamos un sesgo de selecciÃ³n de la gravedad, por lo que nuestros resultados y conclusiones estÃ¡n influenciados por Ã©l. En los pacientes con una prueba serolÃ³gica positiva, pero una PCR negativa, la relaciÃ³n entre la infecciÃ³n por SARS-CoV-2 y las manifestaciones clÃ­nicas no se puede determinar. Sin embargo, este estudio proporciona informaciÃ³n clÃ­nica importante sobre las diferentes formas de presentaciÃ³n clÃ­nica de la COVID-19 en niÃ±os y que puede ayudar a reconocer precozmente a los pacientes con riesgo de complicaciones.</p> <p id="par0200">Este estudio describe una serie de niÃ±os de un solo centro que fueron admitidos para recibir atenciÃ³n hospitalaria con la infecciÃ³n por SARS-CoV-2. Los pacientes con enfermedad respiratoria aislada y sin elevaciÃ³n de los biomarcadores inflamatorios clÃ¡sicos mostraron un curso sin complicaciones de la enfermedad. En estos casos, el uso rutinario de las drogas empÃ­ricas propuestas para el COVID-19 parecÃ­a innecesario. En contraste, los niÃ±os mayores con fiebre, sÃ­ntomas abdominales, elevaciÃ³n de los biomarcadores inflamatorios, linfopenia y una alta proporciÃ³n de neutrÃ³filos/linfocitos desarrollaron un empeoramiento clÃ­nico con <i>shock</i>. Estos pacientes con enfermedad complicada requirieron cuidados intensivos que consistieron en tratamiento de soporte y recibieron medicamentos antivirales y antiinflamatorios. Se necesitan mÃ¡s estudios multicÃ©ntricos y prospectivos para ampliar la base de conocimiento sobre esta nueva enfermedad en los niÃ±os, como el estudio EPICO-AEP que se estÃ¡ llevando a cabo en EspaÃ±a. Sus resultados arrojarÃ¡n mayor luz sobre las cuestiones planteadas en este trabajo.</p> </div> <div class="financiaciÃ³n" title="sec"> <div class="title" tagx="title" title="title">
FinanciaciÃ³n</div> <p id="par0205">Este trabajo no ha recibido ningÃºn tipo de financiaciÃ³n.</p> </div> <div class="conflictodeintereses" title="sec"> <div class="title" tagx="title" title="title">
Conflicto de intereses</div> <p id="par0210">Los autores declaran no tener ningÃºn conflicto de intereses.</p> </div> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
BibliografÃ­a</div> <li tag="ref"><a name="bib0180" /><span class="label" tagx="label" title="label">1</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Prompetchara</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ketloy</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Palaga</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic</span><span class="source" tagx="source" title="source">Asian Pac J Allergy Immunol.</span><span class="volume" tagx="volume" title="volume">38</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">9</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32105090">32105090</a></span></span></li> <li tag="ref"><a name="bib0185" /><span class="label" tagx="label" title="label">2</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tagarro</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Epalza</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Santos</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sanz-Santaeufemia</span><span class="given-names" tagx="given-names" title="given-names">F.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Otheo</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moraleda</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid Spain</span><span class="source" tagx="source" title="source">JAMA Pediatr.</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">e201346</span><span class="comment">10.1001/jamapediatrics.2020.1346</span></span></li> <li tag="ref"><a name="bib0190" /><span class="label" tagx="label" title="label">3</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Gobierno de EspaÃ±a</span></span><span class="source" tagx="source" title="source">ActualizaciÃ³n nÂ° 91. Enfermedad por el coronavirus (COVID-19)</span><span class="year" tagx="year" title="year">2020</span><span class="comment">https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Actualizacion_91_COVID-19.pdf (Accessed 10/05/2020)</span></span></li> <li tag="ref"><a name="bib0195" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Livingston</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bucher</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Coronavirus Disease 2019 (COVID-19) in Italy</span><span class="source" tagx="source" title="source">JAMA.</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">10</span><span class="comment">1001/jama.2020.4344. doi:10.1001/jama.2020.4344</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32633785">32633785</a></span></span></li> <li tag="ref"><a name="bib0200" /><span class="label" tagx="label" title="label">5</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) â€" China, 2020</span><span class="source" tagx="source" title="source">Chin J Epidemiol.</span><span class="year" tagx="year" title="year">2020</span></span></li> <li tag="ref"><a name="bib0205" /><span class="label" tagx="label" title="label">6</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Gobierno de EspaÃ±a</span></span><span class="source" tagx="source" title="source">Estudio nacional de sero-epidemiologÃ­a de la infecciÃ³n por SARS-CoV-2 en EspaÃ±a (ENE-Covid)</span><span class="year" tagx="year" title="year">May 2020</span><span class="comment">Disponible en https://www.mscbs.gob.es/gabinetePrensa/notaPrensa/pdf/ENE-C140520115618104.pdf. 2020</span></span></li> <li tag="ref"><a name="bib0210" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bi</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mei</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ye</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zou</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen China: a retrospective cohort study. [published online ahead of print, 2020 Apr 27] [published correction appears in Lancet Infect Dis. 2020 Jul;20(7):e148]</span><span class="source" tagx="source" title="source">Lancet Infect Dis.</span><span class="volume" tagx="volume" title="volume">S1473â€"3099</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">30287</span><span class="lpage" tagx="lpage" title="lpage">30295</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S1473-3099(20)30287-5">10.1016/S1473-3099(20)30287-5</a></span></span></li> <li tag="ref"><a name="bib0215" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mo</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qi</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China</span><span class="source" tagx="source" title="source">Pediatrics.</span><span class="year" tagx="year" title="year">2020</span><span class="comment">10.1542/peds.2020-0702</span></span></li> <li tag="ref"><a name="bib0220" /><span class="label" tagx="label" title="label">9</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">SARS-CoV-2 Infection in Children</span><span class="source" tagx="source" title="source">N Engl J Med.</span><span class="volume" tagx="volume" title="volume">382</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1663</span><span class="lpage" tagx="lpage" title="lpage">1665</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32187458">32187458</a></span></span></li> <li tag="ref"><a name="bib0225" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mahase</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Covid-19: concerns grow over inflammatory syndrome emerging in children</span><span class="source" tagx="source" title="source">BMJ.</span><span class="volume" tagx="volume" title="volume">369</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1710</span></span></li> <li tag="ref"><a name="bib0230" /><span class="label" tagx="label" title="label">11</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Riphagen</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gonzalez-Martinez</span><span class="given-names" tagx="given-names" title="given-names">G.X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wilkinson</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Theocharis</span><span class="given-names" tagx="given-names" title="given-names">N.P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Hyperinflammatory shock in children during COVID-19 pandemic</span><span class="source" tagx="source" title="source">Lancet.</span><span class="year" tagx="year" title="year">2020</span><span class="comment">doi:org/101016/S0140-6736(20)31094-1Published online May 6 2020</span></span></li> <li tag="ref"><a name="bib0235" /><span class="label" tagx="label" title="label">12</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramcharan</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nolan</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lai</span><span class="given-names" tagx="given-names" title="given-names">C.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Prabhu</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Krishnamurthy</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Richter</span><span class="given-names" tagx="given-names" title="given-names">A.G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. [published online ahead of print, 2020 Jun 12]</span><span class="source" tagx="source" title="source">Pediatr Cardiol.</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">11</span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31673733">31673733</a></span></span></li> <li tag="ref"><a name="bib0240" /><span class="label" tagx="label" title="label">13</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fleming</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thompson</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stevens</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Heneghan</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">PlÃ¼ddemann</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maconochie</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies</span><span class="source" tagx="source" title="source">Lancet.</span><span class="volume" tagx="volume" title="volume">377</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">1011</span><span class="lpage" tagx="lpage" title="lpage">1018</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21411136">21411136</a></span></span></li> <li tag="ref"><a name="bib0245" /><span class="label" tagx="label" title="label">14</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Garazzino</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Montagnani</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">DonÃ </span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meini</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Felici</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vergine</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="collab'">collab: The Italian SITIP-SIP Pediatric Infection Study Group</span></span><span class="mixed-article-title" title="mixed-article-title">Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020</span><span class="source" tagx="source" title="source">Euro Surveill.</span><span class="volume" tagx="volume" title="volume">25</span><span class="year" tagx="year" title="year">2020</span><span class="comment">2000600. https://doi.org/10.2807/1560-7917.ES.18202025</span></span></li> <li tag="ref"><a name="bib0250" /><span class="label" tagx="label" title="label">15</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Parri</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lenge</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Children with Covid-19 in Pediatric Emergency Departments in Italy</span><span class="source" tagx="source" title="source">N Engl J Med.</span><span class="volume" tagx="volume" title="volume">383</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">187</span><span class="lpage" tagx="lpage" title="lpage">190</span><span class="comment">10.1056/NEJMc2007617</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32356945">32356945</a></span></span></li> <li tag="ref"><a name="bib0255" /><span class="label" tagx="label" title="label">16</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Grasselli</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pesenti</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cecconi</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Critical Care Utilization for the COVID-19 Outbreak in Lombardy Italy: Early Experience and Forecast During an Emergency Response</span><span class="source" tagx="source" title="source">JAMA.</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">10</span><span class="comment">1001/jama.2020.4031. 10.1001/jama.2020.4031</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32633785">32633785</a></span></span></li> <li tag="ref"><a name="bib0260" /><span class="label" tagx="label" title="label">17</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guan</span><span class="given-names" tagx="given-names" title="given-names">W.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ni</span><span class="given-names" tagx="given-names" title="given-names">Z.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liang</span><span class="given-names" tagx="given-names" title="given-names">W.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ou</span><span class="given-names" tagx="given-names" title="given-names">C.Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">J.X.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical Characteristics of Coronavirus Disease 2019 in China</span><span class="source" tagx="source" title="source">N Engl J Med.</span><span class="volume" tagx="volume" title="volume">382</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1708</span><span class="lpage" tagx="lpage" title="lpage">1720</span><span class="comment">10.1056/NEJMoa2002032</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32109013">32109013</a></span></span></li> <li tag="ref"><a name="bib0265" /><span class="label" tagx="label" title="label">18</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ludvigsson</span><span class="given-names" tagx="given-names" title="given-names">J.F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults</span><span class="source" tagx="source" title="source">Acta Paediatr.</span><span class="volume" tagx="volume" title="volume">109</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1088</span><span class="lpage" tagx="lpage" title="lpage">1095</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32202343">32202343</a></span></span></li> <li tag="ref"><a name="bib0270" /><span class="label" tagx="label" title="label">19</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan China: a retrospective cohort study</span><span class="source" tagx="source" title="source">Lancet.</span><span class="volume" tagx="volume" title="volume">395</span><span class="issue" tagx="issue" title="issue">10229</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1054</span><span class="lpage" tagx="lpage" title="lpage">1062</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0140-6736(20)30566-3">10.1016/S0140-6736(20)30566-3</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32171076">32171076</a></span></span></li> <li tag="ref"><a name="bib0275" /><span class="label" tagx="label" title="label">20</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mizumoto</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chowell</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Estimating Risk for Death from 2019 Novel Coronavirus Disease, China January-February 2020</span><span class="source" tagx="source" title="source">Emerg Infect Dis.</span><span class="volume" tagx="volume" title="volume">26</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1251</span><span class="lpage" tagx="lpage" title="lpage">1256</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32168464">32168464</a></span></span></li> <li tag="ref"><a name="bib0280" /><span class="label" tagx="label" title="label">21</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wei</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fu</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Z.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China</span><span class="source" tagx="source" title="source">JAMA.</span><span class="volume" tagx="volume" title="volume">323</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1313</span><span class="lpage" tagx="lpage" title="lpage">1314</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32058570">32058570</a></span></span></li> <li tag="ref"><a name="bib0285" /><span class="label" tagx="label" title="label">22</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GonzÃ¡lez Brabin</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Iglesias-Bouzas</span><span class="given-names" tagx="given-names" title="given-names">M.I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nieto-Moro</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MartÃ­nez de Azagra-Garde</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GarcÃ­a-Salido</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Apnea neonatal como manifestaciÃ³n inicial de infecciÃ³n por SARS-CoV-2 [Neonatal apnea as initial manifestation of SARS-CoV-2 infection] [published online ahead of print, 2020 Jun 11]</span><span class="source" tagx="source" title="source">An Pediatr (Barc).</span><span class="volume" tagx="volume" title="volume">S1695â€"4033</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">30191</span><span class="lpage" tagx="lpage" title="lpage">30200</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.anpedi.2020.05.008">10.1016/j.anpedi.2020.05.008</a></span></span></li> <li tag="ref"><a name="bib0290" /><span class="label" tagx="label" title="label">23</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nieto-Moro</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ecclesia</span><span class="given-names" tagx="given-names" title="given-names">F.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">TomÃ©-Masa</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Caro-PatÃ³n</span><span class="given-names" tagx="given-names" title="given-names">G.D.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leoz-Gordillo</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cabrero-HernÃ¡ndez</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">SARS-CoV-2 and Streptococcus pneumoniae coinfection as a cause of severe pneumonia in an infant [published online ahead of print, 2020 Jun 29]</span><span class="source" tagx="source" title="source">Pediatr Pulmonol.</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">10</span><span class="comment">1002/ppul.24916. doi:10.1002/ppul.24916</span></span></li> <li tag="ref"><a name="bib0295" /><span class="label" tagx="label" title="label">24</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhatnagar</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Murhekar</span><span class="given-names" tagx="given-names" title="given-names">M.V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Soneja</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gupta</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Giri</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wig</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use</span><span class="source" tagx="source" title="source">Indian J Med Res.</span><span class="volume" tagx="volume" title="volume">151</span><span class="issue" tagx="issue" title="issue">2 &amp;amp; 3</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">184</span><span class="lpage" tagx="lpage" title="lpage">189</span><span class="comment">10.4103/ijmr.IJMR_502_20</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32362644">32362644</a></span></span></li> <li tag="ref"><a name="bib0300" /><span class="label" tagx="label" title="label">25</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wen</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19</span><span class="source" tagx="source" title="source">N Engl J Med.</span><span class="volume" tagx="volume" title="volume">382</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1787</span><span class="lpage" tagx="lpage" title="lpage">1799</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32187464">32187464</a></span></span></li> <li tag="ref"><a name="bib0305" /><span class="label" tagx="label" title="label">26</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cunningham</span><span class="given-names" tagx="given-names" title="given-names">A.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goh</span><span class="given-names" tagx="given-names" title="given-names">H.P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Koh</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Treatment of COVID-19: old tricks for new challenges</span><span class="source" tagx="source" title="source">Crit Care.</span><span class="volume" tagx="volume" title="volume">24</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">91</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32178711">32178711</a></span></span></li> <li tag="ref"><a name="bib0310" /><span class="label" tagx="label" title="label">27</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gautret</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lagier</span><span class="given-names" tagx="given-names" title="given-names">J.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Parola</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hoang</span><span class="given-names" tagx="given-names" title="given-names">V.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meddeb</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mailhe</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial</span><span class="source" tagx="source" title="source">Int J Antimicrob Agents.</span><span class="volume" tagx="volume" title="volume">56</span><span class="year" tagx="year" title="year">2020</span><span class="comment">105949</span></span></li> <li tag="ref"><a name="bib0315" /><span class="label" tagx="label" title="label">28</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span></span><span class="mixed-article-title" title="mixed-article-title">On the use of corticosteroids for 2019-nCoV pneumonia</span><span class="source" tagx="source" title="source">Lancet.</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">683</span><span class="lpage" tagx="lpage" title="lpage">684</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32122468">32122468</a></span></span></li> <li tag="ref"><a name="bib0320" /><span class="label" tagx="label" title="label">29</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GarcÃ­a-Salido</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leoz-Gordillo</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MartÃ­nez de Azagra-Garde</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nieto-Moro</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Iglesias-Bouzas</span><span class="given-names" tagx="given-names" title="given-names">M.I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GarcÃ­a-Teresa</span><span class="given-names" tagx="given-names" title="given-names">M.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Children in Critical Care Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Experience in a Spanish Hospital [published online ahead of print, 2020 May 27]</span><span class="source" tagx="source" title="source">Pediatr Crit Care Med.</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">10</span><span class="comment">1097/PCC. 0000000000002475. doi:10.1097/PCC. 0000000000002475</span></span></li> <li tag="ref"><a name="bib0325" /><span class="label" tagx="label" title="label">30</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cabrero-HernÃ¡ndez</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GarcÃ­a-Salido</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leoz-Gordillo</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alonso-Cadenas</span><span class="given-names" tagx="given-names" title="given-names">J.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gochi-Valdovinos</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GonzÃ¡lez-Brabin</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Severe SARS-CoV-2 Infection in Children With Suspected Acute Abdomen: A Case Series From a Tertiary Hospital in Spain</span><span class="source" tagx="source" title="source">Pediatr Infect Dis J.</span><span class="volume" tagx="volume" title="volume">39</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">e195</span><span class="lpage" tagx="lpage" title="lpage">e198</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32467457">32467457</a></span></span></li> <li tag="ref"><a name="bib0330" /><span class="label" tagx="label" title="label">31</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Russell</span><span class="given-names" tagx="given-names" title="given-names">C.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Parajuli</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gale</span><span class="given-names" tagx="given-names" title="given-names">H.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bulteel</span><span class="given-names" tagx="given-names" title="given-names">N.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schuetz</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cornelis</span><span class="given-names" tagx="given-names" title="given-names">P.C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis</span><span class="source" tagx="source" title="source">J Infect.</span><span class="volume" tagx="volume" title="volume">78</span><span class="year" tagx="year" title="year">2019</span><span class="fpage" tagx="fpage" title="fpage">339</span><span class="lpage" tagx="lpage" title="lpage">348</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30802469">30802469</a></span></span></li> <li tag="ref"><a name="bib0335" /><span class="label" tagx="label" title="label">32</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiang</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pu</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiong</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage</span><span class="source" tagx="source" title="source">J Transl Med.</span><span class="volume" tagx="volume" title="volume">18</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">206</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32434518">32434518</a></span></span></li> <li tag="ref"><a name="bib0340" /><span class="label" tagx="label" title="label">33</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">B.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chong</span><span class="given-names" tagx="given-names" title="given-names">V.C.L</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">S.S.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lim</span><span class="given-names" tagx="given-names" title="given-names">G.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lim</span><span class="given-names" tagx="given-names" title="given-names">K.G.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tan</span><span class="given-names" tagx="given-names" title="given-names">G.B.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Hematologic parameters in patients with COVID-19 infection</span><span class="source" tagx="source" title="source">Am J Hematol.</span><span class="volume" tagx="volume" title="volume">95</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">131</span><span class="lpage" tagx="lpage" title="lpage">134</span></span></li> <li tag="ref"><a name="bib0345" /><span class="label" tagx="label" title="label">34</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bastidas</span><span class="given-names" tagx="given-names" title="given-names">H.I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MÃ¡rquez-PÃ©rez</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GarcÃ­a-Salido</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Luglietto</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GarcÃ­a-Moreno</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MartÃ­nez de Azagre-Garde</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Cerebral venous sinus thrombosis in a pediatric patient with COVID-19</span><span class="source" tagx="source" title="source">Neurol Clin Pract.</span><span class="year" tagx="year" title="year">2020</span><span class="comment">10.1212/CPJ. 0000000000000899</span></span></li> <li tag="ref"><a name="bib0350" /><span class="label" tagx="label" title="label">35</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GarcÃ­a-Salido</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Three Hypotheses About Children COVID19</span><span class="source" tagx="source" title="source">Pediatr Infect Dis J</span><span class="volume" tagx="volume" title="volume">39</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">e157</span></span></li> </ul> </div> </div>  </body></html>